US Research house initiates Solvonis coverage citing differentiated addiction strategy

Water Tower Research initiated coverage of Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF). The article provides a new analyst starting point on the London-listed biopharma, but no valuation or target price metrics were included, implying limited near-term market impact.

Analysis

Water Tower Research initiated coverage of Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF). The article provides a new analyst starting point on the London-listed biopharma, but no valuation or target price metrics were included, implying limited near-term market impact.